164 related articles for article (PubMed ID: 29042987)
1. Upregulation of Yes-associated protein and transcriptional co-activator with PDZ-binding motif influences the behavior of LOVO human colon adenocarcinoma cells.
Li Y; Li L; Zhu M; Ye L; Yang Q
Exp Ther Med; 2017 Oct; 14(4):3831-3835. PubMed ID: 29042987
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of YAP and TAZ is an independent predictor of prognosis in colorectal cancer and related to the proliferation and metastasis of colon cancer cells.
Wang L; Shi S; Guo Z; Zhang X; Han S; Yang A; Wen W; Zhu Q
PLoS One; 2013; 8(6):e65539. PubMed ID: 23762387
[TBL] [Abstract][Full Text] [Related]
3. TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis.
Wang S; Ma K; Chen L; Zhu H; Liang S; Liu M; Xu N
Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27515420
[TBL] [Abstract][Full Text] [Related]
4. Photosensitizer verteporfin inhibits the growth of YAP- and TAZ-dominant gastric cancer cells by suppressing the anti-apoptotic protein Survivin in a light-independent manner.
Hasegawa T; Sugihara T; Hoshino Y; Tarumoto R; Matsuki Y; Kanda T; Takata T; Nagahara T; Matono T; Isomoto H
Oncol Lett; 2021 Oct; 22(4):703. PubMed ID: 34457058
[TBL] [Abstract][Full Text] [Related]
5. VASN promotes proliferation of laryngeal cancer cells via YAP/TAZ.
Liu H; Kong W; Wen S; Wu J; Yin X; Liu Y
J BUON; 2021; 26(4):1563-1570. PubMed ID: 34565020
[TBL] [Abstract][Full Text] [Related]
6. Yes-associated protein (YAP) and transcriptional coactivator with a PDZ-binding motif (TAZ): a nexus between hypoxia and cancer.
Zhao C; Zeng C; Ye S; Dai X; He Q; Yang B; Zhu H
Acta Pharm Sin B; 2020 Jun; 10(6):947-960. PubMed ID: 32642404
[TBL] [Abstract][Full Text] [Related]
7. The transition of tissue inhibitor of metalloproteinases from -4 to -1 induces aggressive behavior and poor patient survival in dedifferentiated liposarcoma via YAP/TAZ activation.
Shrestha M; Ando T; Chea C; Sakamoto S; Nishisaka T; Ogawa I; Miyauchi M; Takata T
Carcinogenesis; 2019 Oct; 40(10):1288-1297. PubMed ID: 31074490
[TBL] [Abstract][Full Text] [Related]
8. Targeting the Hippo Signaling Pathway for Tissue Regeneration and Cancer Therapy.
Juan WC; Hong W
Genes (Basel); 2016 Aug; 7(9):. PubMed ID: 27589805
[TBL] [Abstract][Full Text] [Related]
9. Effect of Jiawei Tongqiao Huoxue decoction in basilar artery dolichoectasia mice through yes-associated protein/transcriptional co-activator with PDZ-binding motif pathway.
Liu FX; Zhang DP; Ma YM; Zhang HL; Liu XZ; Zhang ZQ; Sun RQ; Zhang YK; Miao JX; Wu ZX; Liu YL; Feng YC
J Ethnopharmacol; 2023 Oct; 314():116599. PubMed ID: 37149070
[TBL] [Abstract][Full Text] [Related]
10. YAP/TAZ-TEAD activity promotes the malignant transformation of cervical intraepithelial neoplasia through enhancing the characteristics and Warburg effect of cancer stem cells.
Li S; Li X; Yang YB; Wu SF
Apoptosis; 2024 Mar; ():. PubMed ID: 38553612
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition.
Shi G; Wang H; Han H; Gan J; Wang H
Exp Ther Med; 2018 Sep; 16(3):2751-2755. PubMed ID: 30210616
[TBL] [Abstract][Full Text] [Related]
12. Expression and localization of Yap and Taz during development of the mandibular first molar in rats.
Zhang B; Sun BY; Ji YW; Zhang YP; Wang XX; Xu X; Wen Y
Biotech Histochem; 2017; 92(3):212-221. PubMed ID: 28402144
[TBL] [Abstract][Full Text] [Related]
13. YAP/TAZ: a promising target for squamous cell carcinoma treatment.
Dong X; Meng L; Liu P; Ji R; Su X; Xin Y; Jiang X
Cancer Manag Res; 2019; 11():6245-6252. PubMed ID: 31360073
[TBL] [Abstract][Full Text] [Related]
14. Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells.
Lee Y; Finch-Edmondson M; Cognart H; Zhu B; Song H; Low BC; Sudol M
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297432
[TBL] [Abstract][Full Text] [Related]
15. YAP and TAZ mediate steroid-induced alterations in the trabecular meshwork cytoskeleton in human trabecular meshwork cells.
Peng J; Wang H; Wang X; Sun M; Deng S; Wang Y
Int J Mol Med; 2018 Jan; 41(1):164-172. PubMed ID: 29115373
[TBL] [Abstract][Full Text] [Related]
16. A Potential Role of YAP/TAZ in the Interplay Between Metastasis and Metabolic Alterations.
Yamaguchi H; Taouk GM
Front Oncol; 2020; 10():928. PubMed ID: 32596154
[TBL] [Abstract][Full Text] [Related]
17. Small molecules inhibiting the nuclear localization of YAP/TAZ for chemotherapeutics and chemosensitizers against breast cancers.
Oku Y; Nishiya N; Shito T; Yamamoto R; Yamamoto Y; Oyama C; Uehara Y
FEBS Open Bio; 2015; 5():542-9. PubMed ID: 26199863
[TBL] [Abstract][Full Text] [Related]
18. VASN promotes proliferation of prostate cancer through the YAP/TAZ axis.
Cui FL; Mahmud AN; Xu ZP; Wang ZY; Hu JP
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6589-6596. PubMed ID: 32633347
[TBL] [Abstract][Full Text] [Related]
19. The effect of YAP expression in tumor cells and tumor stroma on the prognosis of patients with squamous cell carcinoma of the oral cavity floor and oral surface of the tongue.
Szelachowska J; Donizy P; Ratajczak-Wielgomas K; Halon A; Zielecka-Debska D; Lichon K; Maciejczyk A; Lata-Wozniak E; Piotrowska A; Matkowski R
Oncol Lett; 2019 Oct; 18(4):3561-3570. PubMed ID: 31579068
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of a component of the Hippo pathway, TAZ, in human uterine endometrioid adenocarcinoma.
Zhan M; Ikeda JI; Wada N; Hori Y; Nojima S; Tahara SI; Ueda Y; Yoshino K; Kimura T; Morii E
Oncol Lett; 2016 Jun; 11(6):3611-3616. PubMed ID: 27284362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
